QX006N
QX006N is a humanized monoclonal antibody inhibitor targeting human interferon α/β receptor 1 (IFNAR1) . QX006N is promising for research of systemic lupus erythematosus (SLE) and other IFNAR1-related autoimmune diseases[1].
Product Specifications
UNSPSC
12352203
Target
IFNAR
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]Chen X, et al. Structural basis for the recognition of IFNAR1 by the humanized therapeutic monoclonal antibody QX006N for the treatment of systemic lupus erythematosus. Int J Biol Macromol. 2024 May;268 (Pt 2) :131721.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IFNAR1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7078723 Inquire
Recombinant Nitrosococcus oceani NADH-quinone oxidoreductase subunit N 1 (nuoN1), partial
Ask
View Details 
MBS1012489-01 0.02 mg (E-Coli)
Recombinant Chloroflexus aurantiacus DNA replication and repair protein recF (recF)
Ask
View Details MBS1012489-02 0.02 mg (Yeast)
Recombinant Chloroflexus aurantiacus DNA replication and repair protein recF (recF)
Ask
View Details MBS1012489-03 0.1 mg (E-Coli)
Recombinant Chloroflexus aurantiacus DNA replication and repair protein recF (recF)
Ask
View Details